journal article·2014-09-23Open access

Enhancing Radiotherapy by Lipid Nanocapsule-Mediated Delivery of Amphiphilic Gold Nanoparticles to Intracellular Membranes

Yu-Sang Yang, Randy P. Carney, Francesco Stellacci, Darrell J. Irvine

ACS Nano· Volume 8· Issue 9

Abstract

Amphiphilic gold nanoparticles (amph-NPs), composed of gold cores surrounded by an amphiphilic mixed organic ligand shell, are capable of embedding within and traversing lipid membranes. Here we describe a strategy using crosslink-stabilized lipid nanocapsules (NCs) as carriers to transport such membrane-penetrating particles into tumor cells and promote their transfer to intracellular membranes for enhanced radiotherapy of cancer. We synthesized and characterized interbilayer-crosslinked multilamellar lipid vesicles (ICMVs) carrying amph-NPs embedded in the capsule walls, forming Au-NCs. Confocal and electron microscopies revealed that the intracellular distribution of amph-NPs within melanoma and breast tumor cells following uptake of free particles vs Au-NCs was quite distinct and that amph-NPs initially delivered into endosomes by Au-NCs transferred over a period of hours to intracellular membranes through tumor cells, with greater intracellular spread in melanoma cells than breast carcinoma cells. Clonogenic assays revealed that Au-NCs enhanced radiotherapeutic killing of melanoma cells. Thus, multilamellar lipid capsules may serve as an effective carrier to deliver amphiphilic gold nanoparticles to tumors, where the membrane-penetrating properties of these materials can significantly enhance the efficacy of frontline radiotherapy treatments.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Nanopore and Nanochannel Transport Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Materials Science and Engineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland

Ragon Institute of MGH, MIT, and Harvard, Charlestown, Massachusetts 02129, United States

Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, United States

Funding

Army Research Office

References (37)

Show source-provided references
1. Fisher B. · J. Clin. Oncol. · 1998 · 16 · 44110.1200/JCO.1998.16.2.441 ↗
2. Portelance L. · Int. J. Radiat. Oncol. Biol. Phys. · 2001 · 51 · 26110.1016/S0360-3016(01)01664-9 ↗
3. Sause W. T. · Int. J. Radiat. Oncol. Biol. Phys. · 1991 · 20 · 42910.1016/0360-3016(91)90053-7 ↗
4. Jeppesen S. S. · Acta Oncol. · 2013 · 52 · 155210.3109/0284186X.2013.813635 ↗
6. Misawa M. · Nanomedicine · 2011 · 7 · 60410.1016/j.nano.2011.01.014 ↗
7. Rong Y. · Expert Rev. Anticancer Ther. · 2011 · 11 · 30910.1586/era.10.175 ↗
8. Xing L. · Med. Dosim. · 2006 · 31 · 9110.1016/j.meddos.2005.12.004 ↗
9. Santos Mello R. · Med. phys · 1983 · 10 · 7510.1118/1.595378 ↗
10. Jordan A. · J. Magn. Magn. Mater. · 1999 · 201 · 41310.1016/S0304-8853(99)00088-8 ↗
11. O’Neal D. P. · Cancer Lett. · 2004 · 209 · 17110.1016/j.canlet.2004.02.004 ↗
12. Hainfeld J. F. · Phys. Med. Biol. · 2004 · 49 · N30910.1088/0031-9155/49/18/N03 ↗
13. Lin M.-H. · Int. J. Radiat. Biol. · 2009 · 85 · 21410.1080/09553000902748583 ↗
14. Klein S. · Biochem. Biophys. Res. Commun. · 2012 · 425 · 39310.1016/j.bbrc.2012.07.108 ↗
15. Douple E. B. · Br. J. Cancer Suppl. · 1978 · 3 · 98
16. Chithrani D. B. · Radiat. Res. · 2010 · 173 · 71910.1667/RR1984.1 ↗
17. Zhang X.-D. · Adv. Healthc. Mater. · 2014 · 3 · 13310.1002/adhm.201300189 ↗
18. Hainfeld J. F. · J. Pharm. Pharmacol. · 2008 · 60 · 97710.1211/jpp.60.8.0005 ↗
19. Hainfeld J. F. · Phys. Med. Biol. · 2010 · 55 · 304510.1088/0031-9155/55/11/004 ↗
20. Jain S. · Br. J. Radiol. · 2012 · 85 · 10110.1259/bjr/59448833 ↗
21. Joh D. Y. · PLoS One · 2013 · 8
22. Zaki A. A. · ACS Nano · 2014 · 8 · 10410.1021/nn405701q ↗
23. Zhang X.-D. · Biomaterials · 2012 · 33 · 640810.1016/j.biomaterials.2012.05.047 ↗
24. McMahon S. J. · Sci. Rep. · 2011 · 1 · 1810.1038/srep00018 ↗
25. Singh C. · Phys. Rev. Lett. · 2007 · 99 · 410.1103/PhysRevLett.99.226106 ↗
26. Verma A. · Nat. Mater. · 2008 · 7 · 58810.1038/nmat2202 ↗
27. Jewell C. M. · Angew. Chem. Int. Ed. Engl. · 2011 · 50 · 1231210.1002/anie.201104514 ↗
28. Sabella, S.; Carney, R. P.; Brunetti, V.; Malvindi, M. A.; Al-Juffali, N.; Vecchio, G.; Janes, S. M.; Bakr, O. M.; Cingolani, R.; Stellacci, F.et al.P. A General Mechanism for Intracellular Toxicity of Metal-Containing Nanoparticles.Nanoscale 2014, Published Online10.1039/c4nr01234h ↗
29. Van Lehn R. C. · Nano Lett. · 2013 · 13 · 406010.1021/nl401365n ↗
30. Ernsting M. J. · J. Control. Release. · 2013 · 172 · 78210.1016/j.jconrel.2013.09.013 ↗
31. Prabhakar U. · Cancer Res. · 2013 · 73 · 241210.1158/0008-5472.CAN-12-4561 ↗
32. Moon J. J. · Nat. Mater. · 2011 · 10 · 24310.1038/nmat2960 ↗
33. Andersen O. S. · Annu. Rev. Biophys. Biomol. Struct. · 2007 · 36 · 10710.1146/annurev.biophys.36.040306.132643 ↗
34. Mashaghi A. · J. Chem. Phys. · 2012 · 136 · 11470910.1063/1.3694280 ↗
35. Carney R. P. · Biointerphases · 2012 · 7 · 1710.1007/s13758-011-0017-3 ↗
36. Monzavi-Karbassi B. · Int. J. Cancer. · 2007 · 120 · 117910.1002/ijc.22424 ↗
37. Franken N. A. P. · Nat. Protoc. · 2006 · 1 · 231510.1038/nprot.2006.339 ↗